Редактирование: CYP2U1

Cytochrome P450 2U1 (Long-chain fatty acid omega-monooxygenase) (EC 1.14.14.80)

==Publications==

{{medline-entry
|title=Genetic variants associated with lung function: the long life family study.
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/25409777
|abstract=Reduced forced expiratory volume in 1 second (FEV1) and the ratio of FEV1 to forced vital capacity (FVC) are strong predictors of mortality and lung function is higher among individuals with exceptional longevity. However, genetic factors associated with lung function in individuals with exceptional longevity have not been identified. We conducted a genome wide association study (GWAS) to identify novel genetic variants associated with lung function in the Long Life Family Study (LLFS) (n = 3,899). Replication was performed using data from the CHARGE/SpiroMeta consortia. The association between SNPs and FEV1 and FEV1/FVC was analyzed using a linear mixed effects model adjusted for age, age2, sex, height, field center, ancestry principal components and kinship structure to adjust for family relationships separately for ever smokers and never smokers. In the linkage analysis, we used the residuals of the FEV1 and FEV1/FVC, adjusted for age, sex, height, ancestry principal components (PCs), smoking status, pack-years, and field center. We identified nine SNPs in strong linkage disequilibrium in the [[CYP2U1]] gene to be associated with FEV1 and a novel SNP (rs889574) associated with FEV1/FVC, none of which were replicated in the CHARGE/SpiroMeta consortia. Using linkage analysis, we identified a novel linkage peak in chromosome 2 at 219 cM for FEV1/FVC (LOD: 3.29) and confirmed a previously reported linkage peak in chromosome 6 at 28 cM (LOD: 3.33) for FEV1. Future studies need to identify the rare genetic variants underlying the linkage peak in chromosome 6 for FEV1.
|mesh-terms=* Aged
* Cohort Studies
* Female
* Genetic Variation
* Genome-Wide Association Study
* Humans
* Longevity
* Lung
* Male
* Middle Aged
* Polymorphism, Single Nucleotide

|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228089
}}
{{medline-entry
|title=Expression patterns of mouse and human CYP orthologs (families 1-4) during development and in different adult tissues.
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/15752708
|abstract=The present study compared the relative expression pattern of 10 orthologous CYP forms from families 1-4 in cDNA panels of human and mouse fetal and adult tissues. Except for [[CYP1A2]], all of these CYPs exhibited specific patterns of expression during mouse ontogeny, suggesting possible involvement in development. Cyp1a1 and Cyp2r1 were the only two of the orthologs to be expressed only in the E7 mouse; Cyp2s1 was expressed in all stages, including E7, while Cyp2e1 appeared only at E17. Highest expression of the individual CYPs in the different late term human fetal tissues was: thymus, [[CYP1B1]] and [[CYP2U1]]; liver, CYP2E1; brain, [[CYP2R1]], [[CYP1A1]] and CYP4X1; and lung, [[CYP4B1]] and [[CYP2W1]]. In general, the level of individual human CYP transcripts was lower in the fetal than the corresponding adult tissues. The pattern of expression in adult mouse and human tissues was fairly similar for [[CYP1A1]], [[CYP1A2]], [[CYP1B1]], [[CYP2S1]], and [[CYP2U1]] orthologs.
|mesh-terms=* Adult
* Aging
* Animals
* Base Sequence
* Cytochrome P-450 Enzyme System
* DNA, Complementary
* Embryo, Mammalian
* Gene Expression Profiling
* Gene Expression Regulation, Developmental
* Humans
* Mice
* Organ Specificity

|full-text-url=https://sci-hub.do/10.1016/j.abb.2005.02.001
}}